Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. But to influencers on TikTok, ...

Between 2014 to 2018, there has been a switch from brand name to generic cholesterol medications. Despite an increase of individuals being placed on cholesterol-lowering drugs, the switch to generic ...

Up to 10 million Americans will soon have a new option for lowering their cholesterol – at a price of $14,600 a year. The Food and Drug Administration surprised much of the medical community ...

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs ...

New FDA-approved cholesterol drug carries hefty price tag 02:59. Millions of patients with high cholesterol will soon have a promising - but pricey - new option for treatment.

A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.

WASHINGTON — The Justice Department said on Thursday that a top generic drug maker admitted to fixing prices of a popular cholesterol drug and agreed to pay $24.1 million, as part of the ...

High cholesterol is often asymptomatic until a serious event occurs, making proactive treatment and management critical for prevention. According to the Centers for Disease Control and Prevention ...

Cholesterol-lowering drugs called statins are credited with dramatically reducing heart attacks and are some of the most-prescribed pills in the United States. But roughly 10 to 30 percent of ...

The drug, anacetrapib, won't be on the market anytime soon. It needs more testing to see if its dramatic effects on cholesterol will translate into fewer heart attacks, strokes and deaths.

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs ...